Avita Medical | Zahlungsmittel Und Äquivalente



Cash And Equivalent Veränderung Datum
Adcock Ingram Holdings ZAR 89.42M 17.72M 2024-06
Celltrion KRW 972.66B 68.24B 2024-09
Clinuvel Pharmaceuticals AUD 35.2M 3.62M 2024-06
Cochlear AUD 513.6M 28.4M 2024-06
CSL 1.66B 640M 2024-06
Cspc Pharmaceutical 8.37B 3.64B 2024-06
Dianthus Therapeutics USD 22.79M 10.88M 2024-12
Ecofibre AUD 6.74M 4.89M 2024-06
Kangmei Pharma CNY 773.51M 28.83M 2024-09
Knight Therapeutics CAD 5.81M 3.59M 2024-09
Laboratorios Farma EUR 27.19M 17.39M 2024-12
Malin Corporation EUR 35.7M 6.4M 2024-06
Mayne Pharma 110.07M 838K 2024-06
Medical Developments International AUD 9.74M 5.96M 2024-06
Nanosonics AUD 129.55M 126.91M 2024-06
Neuren Pharmaceuticals AUD 3.15M 582K 2024-12
Pacific Edge NZD 21.93M 7.33M 2024-09
Paradigm Biopharmaceuticals 17.82M 15.73M 2024-06
Pharma Mar EUR 63.24M 28.44M 2024-12
Polynovo 45.91M 330K 2024-06
PYC Therapeutics AUD 66.87M 41.46M 2024-06
Qiagen NV USD 663.56M 309.42M 2024-12
Ramsay Health Care AUD 341.1M 321.2M 2024-12
ResMed USD 521.94M 95.58M 2024-12
Sartorius EUR 839.5M 26.1M 2025-03
Sino Biopharmaceutical CNY 8.55B 902.41M 2024-06
Telix Pharmaceuticals 710.35M 587.11M 2024-12
Tilray USD 189.7M 15.49M 2024-11
Zz Pientze Pharmaceu 3.27B 895.19M 2024-09



Avita Medical Zahlungsmittel Und Äquivalente - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.